Balance Sheet

Cash Flow Statement

Amortization of Goodwill Amortization of Goodwill Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued Short-Term Debt repayments

Daily Values

Growth Metrics

Celularity (CELU) Long-Term Debt Issuances (2021 - 2025)

Celularity (CELU) has disclosed Long-Term Debt Issuances for 2 consecutive years, with $1.0 million as the latest value for Q4 2025.

For Q4 2025, Long-Term Debt Issuances changed N/A year-over-year to $1.0 million; the TTM value through Dec 2025 reached $5.9 million, changed N/A, while the annual FY2025 figure was $3.3 million, N/A changed from the prior year.
Long-Term Debt Issuances hit $1.0 million in Q4 2025 for Celularity, down from $4.9 million in the prior quarter.
Across five years, Long-Term Debt Issuances topped out at $4.9 million in Q2 2021 and bottomed at $120000.0 in Q1 2021.